Abstract
SIR WILLIAM BAYLISS'S article in NATURE of February 10, p. 188, displays an attitude of friendly criticism towards the Medical Research Council's policy, in expressing their willingness to accept assignment of the insulin patent from the University of Toronto. The fact that an observer so sympathetic, and having so many opportunities of ascertaining the true nature of the position, should give expression to doubt and disquiet, may well arouse misgiving in a wider circle. There are several points concerning which he is clearly under a misapprehension.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DALE, H. Insulin. Nature 111, 253–254 (1923). https://doi.org/10.1038/111253a0
Issue date:
DOI: https://doi.org/10.1038/111253a0
